JPS5046820A - - Google Patents

Info

Publication number
JPS5046820A
JPS5046820A JP48050403A JP5040373A JPS5046820A JP S5046820 A JPS5046820 A JP S5046820A JP 48050403 A JP48050403 A JP 48050403A JP 5040373 A JP5040373 A JP 5040373A JP S5046820 A JPS5046820 A JP S5046820A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP48050403A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5046820A publication Critical patent/JPS5046820A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP48050403A 1971-06-22 1973-05-08 Pending JPS5046820A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2920771A GB1381872A (en) 1971-06-22 1971-06-22 Pharmaceutical compositions for inhalation

Publications (1)

Publication Number Publication Date
JPS5046820A true JPS5046820A (da) 1975-04-25

Family

ID=10287853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48050403A Pending JPS5046820A (da) 1971-06-22 1973-05-08

Country Status (9)

Country Link
JP (1) JPS5046820A (da)
AU (1) AU462722B2 (da)
CA (1) CA970685A (da)
DE (1) DE2229981C3 (da)
DK (1) DK134970B (da)
FR (1) FR2143163B2 (da)
GB (1) GB1381872A (da)
NL (1) NL176743C (da)
ZA (1) ZA723999B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5047967A (da) * 1973-06-23 1975-04-28

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520247A (en) * 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
EP0266443B1 (en) * 1986-11-03 1993-06-23 Allen W. Jacobs Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
IT1220979B (it) * 1981-06-04 1990-06-21 Lofarma Farma Lab Capsule contenenti un allergene e procedimento per la loro preparazione
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
AU7685200A (en) 1999-10-12 2001-04-23 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
EP1913939B1 (en) 2000-06-27 2017-05-31 Vectura Limited Formulations for use in inhaler devices
ATE517607T1 (de) 2000-11-30 2011-08-15 Vectura Ltd Verfahren zur herstellung von partikeln zur verwendung in einer pharmazeutischen zusammensetzung
ES2689704T3 (es) 2000-11-30 2018-11-15 Vectura Limited Partículas para usar en una composición farmacéutica
AR046225A1 (es) 2003-11-04 2005-11-30 Glaxo Group Ltd Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
TWI363759B (en) 2004-04-27 2012-05-11 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
CN104177448A (zh) 2005-02-10 2014-12-03 葛兰素集团有限公司 使用预分选技术制备乳糖的方法以及由此形成的药物制剂
PT3578169T (pt) 2009-02-26 2024-07-29 Glaxo Group Ltd Formulações farmacêuticas compreendendo 4-{(1r)-2-[(2,6- diclorobenzil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2- (hidroximetil)fenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
EP3910324A1 (en) 2018-08-07 2021-11-17 Norton (Waterford) Limited Application of raman spectroscopy for the manufacture of inhalation powders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1122284A (en) * 1965-03-19 1968-08-07 Fisons Pharmaceuticals Ltd Inhalation device
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5047967A (da) * 1973-06-23 1975-04-28
JPS6245846B2 (da) * 1973-06-23 1987-09-29 Schering Ag

Also Published As

Publication number Publication date
CA970685A (en) 1975-07-08
ZA723999B (en) 1973-06-27
NL176743B (nl) 1985-01-02
DE2229981A1 (de) 1972-12-28
NL176743C (nl) 1985-06-03
AU4380572A (en) 1974-01-03
DE2229981C3 (de) 1981-04-02
DK134970C (da) 1977-07-18
FR2143163A2 (da) 1973-02-02
DK134970B (da) 1977-02-21
GB1381872A (en) 1975-01-29
DE2229981B2 (de) 1980-07-03
NL7208207A (da) 1972-12-28
FR2143163B2 (da) 1975-10-31
AU462722B2 (en) 1975-07-03

Similar Documents

Publication Publication Date Title
FR2143163B2 (da)
ATA136472A (da)
AR196074A1 (da)
AU2658571A (da)
AU2691671A (da)
AU2742671A (da)
AU2485671A (da)
AU2684071A (da)
AU2588771A (da)
AU2456871A (da)
AU2740271A (da)
AU2415871A (da)
AU2726271A (da)
AU2706571A (da)
AU2836771A (da)
AU2684171A (da)
AU2837671A (da)
AR199640Q (da)
AU2669471A (da)
AU2854371A (da)
AU2654071A (da)
AU2875571A (da)
AU3038671A (da)
AR202997Q (da)
AU2577671A (da)